Alzamend Neuro Inc Cash Flow-to-Debt Ratio
Alzamend Neuro Inc cash flow-to-debt ratio. Alzamend Neuro Inc (ALZN) has a Cash Flow-to-Debt Ratio of -0.42x as of July 2026, meaning its operating cash flow of $-1.14 Million could theoretically repay 0% of its total liabilities ($2.74 Million) in one year. See Alzamend Neuro Inc (ALZN) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Alzamend Neuro Inc (2016–2026)
Cash flow-to-debt ratio of Alzamend Neuro Inc from 2016 to 2026. Historical debt coverage capacity for Alzamend Neuro Inc across 11 annual periods. Also explore net asset momentum of Alzamend Neuro Inc to track the company's year-over-year net asset growth rate.
Alzamend Neuro Inc Cash Flow-to-Debt Ratio by Year (2016–2026)
Alzamend Neuro Inc cash flow-to-debt ratio by year from 2016 to 2026. Year-by-year debt coverage analysis for Alzamend Neuro Inc. For the full cash flow conversion analysis, see Alzamend Neuro Inc (ALZN) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -5.99x | $-8.07 Million | $1.35 Million | ▲ +42.1% |
| 2025 | -10.35x | $-6.57 Million | $634.76K | ▼ -303.6% |
| 2024 | -2.56x | $-8.27 Million | $3.23 Million | ▲ +17.5% |
| 2023 | -3.11x | $-8.92 Million | $2.87 Million | ▲ +45.2% |
| 2022 | -5.68x | $-6.61 Million | $1.16 Million | ▼ -88.3% |
| 2021 | -3.01x | $-2.71 Million | $899.64K | ▼ -27.5% |
| 2020 | -2.36x | $-2.35 Million | $992.31K | ▼ -167.8% |
| 2019 | -0.88x | $-1.05 Million | $1.18 Million | ▲ +95.8% |
| 2018 | -21.21x | $-2.05 Million | $96.72K | ▼ -973.9% |
| 2017 | -1.98x | $-1.42 Million | $717.22K | ▼ -228.1% |
| 2016 | -0.60x | $-18.49K | $30.72K | — |